Change Healthcare Inc. [NASDAQ: CHNG] jumped around 0.05 points on Wednesday, while shares priced at $23.14 at the close of the session, up 0.22%. The company report on June 22, 2022 that Change Healthcare, in Collaboration with Luma Health, Launches Patient Engagement, a Suite of Technology Solutions to Unify the Patient Healthcare Journey.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free.
Suite combines Luma Health’s Patient Success Platform™ solution with Change Healthcare’s revenue cycle management solutions to give patients and providers a cohesive experience that spans the entire healthcare journey.
Today Change Healthcare (NASDAQ: CHNG) launched Patient Engagement, a suite of solutions that seamlessly connects touchpoints across the patient journey, increasing access and improving communication between patients and providers. Change Healthcare’s proven revenue cycle management capabilities and Luma Health’s industry-leading solutions enable providers to unify operational, clinical, and financial journeys, creating a more streamlined experience for patients.
Change Healthcare Inc. stock is now 8.23% up from its year-to-date (YTD) trading value. CHNG Stock saw the intraday high of $23.28 and lowest of $22.97 per share. The company’s 52-week high price is 24.12, which means current price is +21.98% above from all time high which was touched on 05/31/22.
Compared to the average trading volume of 2.86M shares, CHNG reached a trading volume of 5527074 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Change Healthcare Inc. [CHNG]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CHNG shares is $26.78 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CHNG stock is a recommendation set at 2.30. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Credit Suisse have made an estimate for Change Healthcare Inc. shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on April 01, 2022. The new note on the price target was released on February 04, 2022, representing the official price target for Change Healthcare Inc. stock. Previously, the target price had yet another raise to $25.75, while JP Morgan analysts kept a Neutral rating on CHNG stock.
The Average True Range (ATR) for Change Healthcare Inc. is set at 0.39, with the Price to Sales ratio for CHNG stock in the period of the last 12 months amounting to 2.07. The Price to Book ratio for the last quarter was 2.30, with the Price to Cash per share for the same quarter was set at 0.81. Price to Free Cash Flow for CHNG in the course of the last twelve months was 17.14 with Quick ratio for the last quarter at 1.20.
How has CHNG stock performed recently?
Change Healthcare Inc. [CHNG] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 0.48. With this latest performance, CHNG shares gained by 0.39% in over the last four-week period, additionally plugging by 11.95% over the last 6 months – not to mention a drop of -0.04% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CHNG stock in for the last two-week period is set at 47.93, with the RSI for the last a single of trading hit 47.51, and the three-weeks RSI is set at 49.33 for Change Healthcare Inc. [CHNG]. The present Moving Average for the last 50 days of trading for this stock 23.38, while it was recorded at 22.96 for the last single week of trading, and 21.63 for the last 200 days.
Change Healthcare Inc. [CHNG]: Deeper insight into the fundamentals
Change Healthcare Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.20 and a Current Ratio set at 1.20.
Earnings analysis for Change Healthcare Inc. [CHNG]
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for CHNG. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Change Healthcare Inc. go to 13.00%.
Insider trade positions for Change Healthcare Inc. [CHNG]
There are presently around $7,090 million, or 99.20% of CHNG stock, in the hands of institutional investors. The top three institutional holders of CHNG stocks are: BLACKSTONE INC. with ownership of 59,620,253, which is approximately 0% of the company’s market cap and around 1.60% of the total institutional ownership; VANGUARD GROUP INC, holding 21,658,561 shares of the stock with an approximate value of $500.1 million in CHNG stocks shares; and CLARKSTON CAPITAL PARTNERS, LLC, currently with $437.32 million in CHNG stock with ownership of nearly 0.283% of the company’s market capitalization.
145 institutional holders increased their position in Change Healthcare Inc. [NASDAQ:CHNG] by around 37,590,642 shares. Additionally, 132 investors decreased positions by around 36,305,742 shares, while 50 investors held positions by with 233,178,363 shares. The mentioned changes placed institutional holdings at 307,074,747 shares, according to the latest SEC report filing. CHNG stock had 50 new institutional investments in for a total of 10,272,739 shares, while 44 institutional investors sold positions of 11,751,042 shares during the same period.